Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxSelling, General & Administrative
Others
Ratios

Groove Botanicals (GRVE) EBT (2016 - 2017)

Groove Botanicals' EBT history spans 8 years, with the latest figure at -$58255.0 for Q1 2017.

  • For Q1 2017, EBT rose 97.57% year-over-year to -$58255.0; the TTM value through Mar 2017 reached -$211552.0, up 91.55%, while the annual FY2025 figure was -$130834.0, 52.13% up from the prior year.
  • EBT for Q1 2017 was -$58255.0 at Groove Botanicals, up from -$92705.0 in the prior quarter.
  • Across five years, EBT topped out at $209329.0 in Q1 2015 and bottomed at -$2.4 million in Q1 2016.
  • The 5-year median for EBT is -$116374.0 (2014), against an average of -$219091.0.
  • The largest annual shift saw EBT surged 235.41% in 2015 before it plummeted 1243.36% in 2016.
  • A 5-year view of EBT shows it stood at -$158601.0 in 2013, then skyrocketed by 169.34% to $109977.0 in 2014, then crashed by 217.65% to -$129385.0 in 2015, then increased by 28.35% to -$92705.0 in 2016, then soared by 37.16% to -$58255.0 in 2017.
  • Per Business Quant, the three most recent readings for GRVE's EBT are -$58255.0 (Q1 2017), -$92705.0 (Q4 2016), and -$28369.0 (Q3 2016).